Condition: Merkel Cell Carcinoma, Stage I · Merkel Cell Carcinoma, Stage II · Neoadjuvant Immunotherapy · Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
The study is a randomized, double blind, placebo-controlled, non-comparative phase II trial that investigates the efficacy of neoadjuvant anti-PD-1 antibody Cemiplimab treatment in patients with clinical stage I or II Merkel cell carcinoma who have have undergone primary tumour excision and are pending sentinel lymph node biopsy.
This description comes directly from the study's public registry record.
Ralf Gutzmer, Prof. Dr. med. · Ralf.Gutzmer@Muehlenkreiskliniken.de
Michelle Tez · tez.michelle@ikf-khnw.de
Always discuss trial participation with your own doctor first.
| Nationales Centrum für Tumorerkrankungen | Heidelberg, Baden-Wurttemberg, Germany | Recruiting |
| Universitätsklinikum Mannheim | Mannheim, Baden-Wurttemberg, Germany | Recruiting |
| Universitätsklinikum Tübingen | Tübingen, Baden-Wurttemberg, Germany | Recruiting |
| Universitätsklinikum Regensburg | Regensburg, Bavaria, Germany | Not Yet Recruiting |
| Universitätsklinikum Würzburg | Würzburg, Bavaria, Germany | Recruiting |
| Universitätsklinikum Hamburg-Eppendorf | Hamburg, Free and Hanseatic City of Hamburg, Germany | Recruiting |
| Universitätsklinikum Frankfurt | Frankfurt am Main, Hesse, Germany | Not Yet Recruiting |
| Klinikum Bielefeld | Bielefeld, North Rhine-Westphalia, Germany | Recruiting |
| Universitätsklinikum Köln | Cologne, North Rhine-Westphalia, Germany | Not Yet Recruiting |
| Universitätsklinikum Essen | Essen, North Rhine-Westphalia, Germany | Recruiting |
| Johannes Wesling Klinikum Minden | Minden, North Rhine-Westphalia, Germany | Not Yet Recruiting |
| Universitätsmedizin Mainz | Mainz, Rhineland-Palatinate, Germany | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07387198